DENVER, Colo., July 1, 2019- (24/7MarketNews via COMTEX) Venture Market News for July 1, 2019.
CytoDyn Anticipates Revenue Commencing in August 2019 from Use of PA-14 and/or PRO 140 in Diagnostic Test
CytoDyn Signs Non-binding Agreement for Diagnostic License and Supply Agreement with IncellDX for PA-14 and/or PRO 140 (non-commercial grade)
Collaboration represents an immediate revenue opportunity as a diagnostic test for receptor occupancy and the existence of CCR5 on cancer tissue and in HIV
VANCOUVER, Washington, July 01, 2019 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications today announced a non-binding agreement with IncellDX, Inc. for a diagnostic license and supply agreement for the PA-14 antibody (the diagnostic designation of the murine version of PRO 140) and PRO 140, which is humanized PA-14. Assays to determine the existence of CCR5 on cancer tissue and the receptor occupancy level for HIV patients are believed to be integral for the effective introduction of leronlimab for therapeutic benefits in this patient population.
Chemesis International Inc. Announces $6,000,000 USD Annual Minimum Purchase Order with PR ONE for Dry Flower & Cannabis Infused Goods
VANCOUVER, British Columbia, July 01, 2019 (GLOBE NEWSWIRE) — Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), through its subsidiary, Natural Ventures, announces it has signed an exclusive manufacturing agreement with PR ONE, a Puerto Rico based medical cannabis company. PR ONE’s flagship store is located in the San Juan Metro area and has over 6,000 ft2 of retail floor space. They are also currently working towards opening additional locations to meet growing demand from cannabis consumers.
Netlist Updates Status of ITC Investigation of SK hynix
Judge Grants Netlist Motion to Strike and Preclude Arguments and Evidence Alleging Invalidity of ‘623 Patent-
IRVINE, Calif., July 1, 2019 /PRNewswire/ — Netlist, Inc. (OTCQX: NLST) today announced that on June 26, 2019 Chief Administrative Law Judge (CALJ) Bullock of the United States International Trade Commission (ITC) issued an order regarding ITC Investigation Number 337-TA-1089. The order grants Netlist’s June 7, 2019 Motion to Strike and Preclude SK hynix’s Arguments and Evidence Alleging Invalidity of U.S. Patent No. 9,535,623. As a result of the order, SK hynix will not be allowed to enter evidence at the ITC hearing that would challenge the validity of Netlist’s ‘623 patent.
KushCo Holdings to Report Third Fiscal Quarter 2019 Earnings on Tuesday, July 9, 2019
GARDEN GROVE, CA / ACCESSWIRE / July 1, 2019 / KushCo Holdings, Inc. (OTCQX: KSHB) (“KushCo” or the “Company”) today announced it will issue its fiscal third quarter 2019 results press release on July 9, 2019 after U.S. markets close.
Connect with 24/7 Market News on social media:
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.
24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.
The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. 24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.
For further information on 24/7 Market News, please go to www.247marketnews.com
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan,” or “planned,” “will,” or “should,” “expected,” “anticipates,” “draft,” “eventually,” or “projected.” You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements
24/7 Market News